Following this observation, we aimed to investigate whether the potential beneficial effect of phosphatidylcholine supplementation was associated with the fact that the boy carries susceptibility variants in the first intron of DGKH for bipolar disorder. The gene discussed is DGKH; the disease is bipolar disorder.